NAV
₹52.5970
as of 13 Nov 2026
Expense Ratio
0.75%
Lumpsum returns (CAGR)
- 1Y
- +20.18%
- 3Y
- +21.74%
- 5Y
- +17.17%
- Since Inception
- +23.21%
SIP returns (XIRR)
- 1Y
- +30.83%
- 3Y
- +17.22%
- 5Y
- +20.48%
- Since Inception
- +22.23%
Returns calculated from 12 November 2018 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
Performance Comparison
Sectoral allocation
as of 31 Oct 2026- Pharmaceuticals & Biotechnology66.01%
- Healthcare Services20.81%
- Healthcare Equipment & Supplies9.00%
- Insurance1.02%
Each sector links to the mutual funds most exposed to it.
Thinking about DSP Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with DSP Healthcare Fund - Regular Plan - Growth
- 1Apollo Hospitals Enterprise Limited7.89%
- 2Ipca Laboratories Limited7.49%
- 3Cipla Limited7.40%
- 4Sun Pharmaceutical Industries Limited7.32%
- 5Gland Pharma Limited6.61%
- 6Sai Life Sciences Limited6.17%
- 7Globus Medical Inc5.36%
- 8Alkem Laboratories Limited4.73%
- 9Divi'S Laboratories Limited4.41%
- 10Cohance Lifesciences Limited3.82%
What this fund does
DSP Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
DSP Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by DSP Mutual Fund. The fund has been operational for over 8 years. It benchmarks its performance against BSE Healthcare TRI. The current expense ratio is 0.75%.